GMED Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$105.75median target· current $77.00 (+37.3%)13 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio17.99Forward 16.95
EPS (TTM)$4.2866.7% YoY
Profit margin18.9%HEALTHCARE
Market cap$10.45BLarge cap
Valuation
- Forward P/E
- 16.95
- PEG ratio
- 1.73
- P/B
- 2.21
- P/S (TTM)
- 3.37
- EV/EBITDA
- 11.27
Profitability & growth
- ROE (TTM)
- 13.3%
- Operating margin
- 21.3%
- Revenue growth YoY
- 27.0%
- Dividend yield
- —
- Beta
- 0.95
Last earnings
May 7, 2026 · Estimate $0.92 · Reported $1.12
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Globus Medical
Company profileGlobus Medical, Inc., a medical device company, develops and markets healthcare solutions for patients with musculoskeletal disorders. The company is headquartered in Audubon, Pennsylvania.
Classification
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$10.45B
Shares outstanding$113.3M
52W high$101.40
52W low$51.79
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent